Tchaikapharma High Quality Medicines AD (BUL: THQM)

Market Cap	1.65B
Revenue (ttm)	49.85M
Net Income (ttm)	3.34M
Shares Out	91.80M
EPS (ttm)	0.04
PE Ratio	495.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60
Average Volume	213
Open	18.00
Previous Close	n/a
Day's Range	18.00 - 18.00
52-Week Range	17.00 - 18.00
Beta	0.03
RSI	63.26
Earnings Date	Feb 25, 2025

About BUL: THQM

Tchaikapharma High Quality Medicines AD engages in the development and manufacture of generic and in-licensed medicines in Bulgaria. The company offers anaesthetic, anti-inflammatory and anti-rheumatic, antibiotic, cardiovascular system, digestive system, diabetes and metabolism, nervous system, OTC, respiratory system, oncology, and other medicines. It also provides nutritional supplements. The company was founded in 1999 and is headquartered in Sofia, Bulgaria.

• Industry: Pharmaceutical Preparations
• Founded: 1999
• Employees: 191
• Stock Exchange: Bulgarian Stock Exchange
• Ticker Symbol: THQM

Financial Performance

In 2023, THQM's revenue was 48.51 million, an increase of 12.44% compared to the previous year's 43.15 million. Earnings were 3.40 million, an increase of 21.79%.